Jennison Associates
ABMD

Jennison Associates’s Abiomed Inc ABMD Stock Holding History

Jennison Associates’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-54,245
Closed -$9.65M – 690
2019
Q3 		$9.65M Sell
54,245
-5,025
-8% -$1.09M 0.01% 405
2019
Q2 		$15.4M Buy
59,270
+17,731
+43% +$4.7M 0.02% 388
2019
Q1 		$11.9M Sell
41,539
-4
-0% -$1.33K 0.01% 419
2018
Q4 		$13.5M Buy
41,543
+861
+2% +$299K 0.02% 404
2018
Q3 		$18.3M Buy
+40,682
New +$16M 0.02% 411
2018
Q2 		– Sell
-55,032
Closed -$16M – 719
2018
Q1 		$16M Sell
55,032
-68,507
-55% -$17.4M 0.02% 419
2017
Q4 		$23.2M Buy
123,539
+24,048
+24% +$4.49M 0.02% 375
2017
Q3 		$16.8M Hold
99,491
– – 0.02% 427
2017
Q2 		$14.3M Sell
99,491
-3,858
-4% -$518K 0.02% 447
2017
Q1 		$12.9M Buy
+103,349
New +$12M 0.01% 472
2016
Q3 		– Sell
-2,736
Closed -$299K – 689
2016
Q2 		$299K Sell
2,736
-171
-6% -$17K ﹤0.01% 620
2016
Q1 		$276K Buy
+2,907
New +$245K ﹤0.01% 599

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Jennison Associates's ABMD Position: Q4 2019 in Review

Jennison Associates sold out of Abiomed Inc (ABMD) in Q4 2019, closing a stake of 54,245 shares — an estimated $9.65M sold.

Jennison Associates first reported a position in ABMD in Q1 2016 and held it in 12 quarters. The position peaked at $23.2M in Q4 2017. 465 funds tracked by Wall St. Rank hold ABMD as of Q4 2019.

  • Jennison Associates reported no remaining Abiomed Inc position as of Q4 2019 after selling out during the quarter.
  • Jennison Associates sold 54,245 Abiomed Inc shares in Q4 2019, an estimated $9.65M.
  • Jennison Associates first reported a position in Abiomed Inc in Q1 2016 and held it in 12 quarters.
  • Jennison Associates's Abiomed Inc position peaked at $23.2M in Q4 2017.
  • 465 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2019.

Based on Jennison Associates's 13F filing for Q4 2019, filed 7 Feb 2020.